{
    "SPADE_UN_18931": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18931",
            "Peptide Name": "YZ106 (Synthetic AMPs, teixobactin-derived, Leu-rich, XXA, UCLL1c)",
            "Source": "designed, bacteria-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FLSKILSTLRILL",
            "Sequence Length": 13,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-MRSA",
                "Hemolytic"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1516.91,
            "PI": 11.0,
            "Hydrophobicity": 1.55,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Wu Q, Mishra B, Wang G. 2022",
                    "Reference": "Pept Sci (Hoboken). 2022 Sep;114(5):e24269. doi: 10.1002/pep2.24269.PubMed",
                    "Title": "Linearized teixobactin is inactive and after sequence enhancement, kills methicillin-resistant Staphylococcus aureus via a different mechanism."
                }
            ],
            "Frequent Amino Acids": "LIS",
            "Absent Amino Acids": "ACDEGHMNOPQUVWY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 5,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Net Charge": 2,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (92.31%) toYZ105L: 38%, I=S: 15%.Activity: active against S. aureus USA300 LAC (MIC 2 uM),\tS. epidermidis 1457 (MIC 1-2 uM), E. coli E423-17 (MIC 8-16 uM), \tA. aumannii B28-16 (MIC 8 uM),\tP-aeruginosa E411-17 (MIC > 16 uM), and\tK-pneumoniae E406-17 (MIC > 16 uM).In vitro toxicity: human RBC HC50 50 uM, hemolytic.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_18930",
                    "Similarity": 0.9230769230769231,
                    "Sequence": "FLSQILSTLRILL"
                },
                {
                    "SPADE_ID": "SPADE_UN_18932",
                    "Similarity": 0.9230769230769231,
                    "Sequence": "FLSKILSTLRILF"
                },
                {
                    "SPADE_ID": "SPADE_N_01612",
                    "Similarity": 0.8333333333333334,
                    "Sequence": "SIFPAIVSFLSKFL"
                }
            ]
        }
    }
}